Renal - Chronic
Device Renal
General payments
$280,978
Research payments
$403,900
Through program year 2025, $280,978 in general payments and $403,900 in research payments were reported against Renal - Chronic (Renal).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $128,145 | 531 |
| 2025 | Research | $234,955 | 3 |
| 2024 | General | $4,353 | 63 |
| 2023 | General | $3,132 | 43 |
| 2022 | General | $11,382 | 36 |
| 2021 | General | $55,043 | 4 |
| 2021 | Research | $70,250 | 1 |
| 2020 | General | $51,190 | 4 |
| 2019 | General | $27,733 | 16 |
| 2019 | Research | $98,695 | 1 |
Breakdown
The top 5 of 94 recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 28 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
697 general · 5 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.